100+ Total results for product and free and sample content found
TrialScope Disclose
30 Mar 2023
Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials.
Citeline
01 Mar 2023
Citeline reveals the shortlist for excellence in clinical research and development
Chemist and Druggist News
22 Feb 2023
Workload, Stress Among Reasons Cited for Job Dissatisfaction
Primal Pictures
14 Feb 2023
The collaboration features explanatory videos, interactive models, clinical content & self-assessment exercises
Citeline
10 Feb 2023
Recognizing the biggest breakthroughs in pharma and biotech
Citeline Connect
31 Jan 2023
Next-generation SaaS technology will enable study sponsors and CROs to better design, plan, and monitor clinical trials, from feasibility to start-up through enrollment
Scrip
By Ian Schofield 29 Nov 2022
Bristol-Myers Squibb has withdrawn its EU application to extend Opdivo’s use to metastatic colorectal cancer (mCRC), following a similar move for liver cancer last year. But the mCRC withdrawal is likely to have limited commercial impact and the company is more interested in pursuing the product’s use in combination treatment for this indication.
Topic Cancer
Trial Results Summaries
25 Nov 2022
What Are Trial Results Summaries and Why Are They Necessary?
Topic Clinical Trials
Trial Results Summaries
25 Nov 2022
Trial Results Summaries provides an unbiased and non-promotional portal for sponsors to share trial results summaries, also known as plain language summaries (PLS), with participants and the public.
Topic Clinical Trials
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: